Veeva Pulse Field Trends Report

As the pharmaceutical industry continues to adapt to HCP preferences and hybrid commercial models, it’s critical to stay on top of evolving field and engagement trends.

Each quarter, the Veeva Pulse Field Trends Report provides unique insights into global and regional engagement trends based on an analysis of 600 million HCP interactions across more than 80% of biopharmas worldwide.

Reach out to Veeva Business Consulting to learn how connected sales, marketing, and medical deliver a better customer experience.

Veeva Pulse Insights Q2 2025

It’s Time to Set Shared Medical-Commercial
Goals to Accelerate Treatment

The Q2 2025 Pulse Field Trends Report focuses on measuring and rewarding team collaboration to create a connected flow of information and resources.

Shared goals accelerate the customer journey; AI strengthens teaming through connected insights

Veeva Pulse Field Trends data show that when medical and commercial teams work together to build stakeholder knowledge and trust, they accelerate treatment adoption. Joint KPIs set up AI to power connected engagement through automated teaming, surfacing insights and content so each interaction informs the next. However, very few organizations have established metrics for serving stakeholders with aligned messages in a coordinated way.

71% of leaders say operating models are the main barrier

Executive sponsorship is needed to steer medical and commercial teams toward joint goals and clear up misconceptions about compliance firewalls. Compliance professionals can help remove unnecessary hurdles to collaboration and advise on shared KPIs.

Start with shared goals, then pull through process and incentive changes

A cultural and operational shift of this size requires time for larger organizations, while smaller and pre-commercial biopharmas have the opportunity to establish connected models quickly and early.

Read the report to learn the key steps to put this into practice.